10.32
Avantor Inc stock is traded at $10.32, with a volume of 8.32M.
It is up +3.10% in the last 24 hours and up +14.79% over the past month.
Avantor Inc provides products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company operates through two segments: Laboratory Solutions and Bioscience Production. It offers materials & consumables, equipment & instrumentation, and services & specialty procurement. Product groups include Equipment & Instrumentation, Services & Specialty Procurement, Proprietary Materials & Consumables, and Third-Party Materials & Consumables. Materials & consumables include high-purity chemicals and reagents, lab supplies, customized excipients, single-use assemblies, chromatography products, sample preparation kits, and fluid handling solutions. It operates in the Americas, Europe, and AMEA.
See More
Previous Close:
$10.01
Open:
$10.1
24h Volume:
8.32M
Relative Volume:
0.89
Market Cap:
$7.05B
Revenue:
$6.55B
Net Income/Loss:
$-551.40M
P/E Ratio:
-12.77
EPS:
-0.8082
Net Cash Flow:
$438.90M
1W Performance:
+2.38%
1M Performance:
+14.79%
6M Performance:
-9.95%
1Y Performance:
-25.70%
Avantor Inc Stock (AVTR) Company Profile
Name
Avantor Inc
Sector
Industry
Phone
(610) 386-1700
Address
RADNOR CORPORATE CENTER, BUILDING ONE, RADNOR, PA
Compare AVTR vs ISRG, BDX, MDLN, ALC, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
AVTR
Avantor Inc
|
10.32 | 6.76B | 6.55B | -551.40M | 438.90M | -0.8082 |
|
ISRG
Intuitive Surgical Inc
|
426.01 | 140.84B | 10.58B | 3.00B | 2.83B | 8.2437 |
|
BDX
Becton Dickinson Co
|
158.08 | 41.70B | 21.37B | 1.41B | 3.07B | 3.9437 |
|
MDLN
Medline Inc
|
43.19 | 33.35B | 29.14B | 1.07B | 1.05B | 1.1956 |
|
ALC
Alcon Inc
|
69.66 | 32.72B | 10.63B | 819.00M | 1.59B | 1.6577 |
|
RMD
Resmed Inc
|
209.63 | 28.27B | 5.54B | 1.52B | 1.74B | 10.37 |
Avantor Inc Stock (AVTR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-06-26 | Downgrade | Barclays | Equal Weight → Underweight |
| Jan-05-26 | Downgrade | Evercore ISI | Outperform → In-line |
| Dec-17-25 | Downgrade | Jefferies | Hold → Underperform |
| Dec-15-25 | Downgrade | BofA Securities | Buy → Neutral |
| Nov-04-25 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Oct-30-25 | Downgrade | Barclays | Overweight → Equal Weight |
| Oct-30-25 | Downgrade | JP Morgan | Overweight → Neutral |
| Aug-01-25 | Downgrade | Jefferies | Buy → Hold |
| Apr-29-25 | Downgrade | Goldman | Buy → Neutral |
| Apr-28-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Apr-28-25 | Downgrade | Stifel | Buy → Hold |
| Apr-28-25 | Downgrade | TD Cowen | Buy → Hold |
| Jan-17-25 | Downgrade | UBS | Buy → Neutral |
| Aug-28-24 | Initiated | Wells Fargo | Overweight |
| Jul-10-24 | Downgrade | Citigroup | Buy → Neutral |
| Jan-04-24 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-11-23 | Upgrade | TD Cowen | Market Perform → Outperform |
| Sep-28-23 | Initiated | Bernstein | Mkt Perform |
| Jul-31-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Jul-31-23 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jun-21-23 | Initiated | RBC Capital Mkts | Outperform |
| Dec-14-22 | Initiated | Deutsche Bank | Hold |
| Oct-05-22 | Upgrade | Citigroup | Neutral → Buy |
| Sep-14-22 | Downgrade | Cowen | Outperform → Market Perform |
| Sep-09-22 | Downgrade | Cleveland Research | Buy → Neutral |
| Aug-25-22 | Initiated | Credit Suisse | Neutral |
| Apr-04-22 | Downgrade | Citigroup | Buy → Neutral |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Aug-30-21 | Resumed | Raymond James | Outperform |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Aug-02-21 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jun-04-21 | Initiated | Goldman | Buy |
| Apr-29-21 | Upgrade | Stifel | Hold → Buy |
| Mar-03-21 | Initiated | Barclays | Overweight |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Sep-14-20 | Initiated | Morgan Stanley | Overweight |
| Jul-15-20 | Upgrade | Cleveland Research | Neutral → Buy |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Nov-15-19 | Initiated | Stifel | Hold |
| Aug-02-19 | Initiated | Cleveland Research | Neutral |
| Jun-14-19 | Initiated | Janney | Buy |
| Jun-12-19 | Initiated | Raymond James | Outperform |
| Jun-11-19 | Initiated | Goldman | Buy |
| Jun-11-19 | Initiated | Guggenheim | Buy |
| Jun-11-19 | Initiated | JP Morgan | Overweight |
| Jun-11-19 | Initiated | Jefferies | Buy |
| Jun-11-19 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jun-11-19 | Initiated | Piper Jaffray | Neutral |
| Jun-11-19 | Initiated | RBC Capital Mkts | Outperform |
| Jun-11-19 | Initiated | Robert W. Baird | Outperform |
| Jun-11-19 | Initiated | SunTrust | Buy |
| Jun-11-19 | Initiated | UBS | Buy |
| Jun-11-19 | Initiated | William Blair | Outperform |
View All
Avantor Inc Stock (AVTR) Latest News
Bronstein, Gewirtz & Grossman, LLC Encourages Avantor, Inc. (AVTR) Investors to Inquire about Securities Investigation - ACCESS Newswire
Avantor® to Report Second Quarter 2026 Earnings on Wednesday, July 29, 2026 - BioSpace
Avantor, Inc. (AVTR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Join Class Action to Recover Losses from Avantor, Inc. (AVTR) – Contact Levi & Korsinsky Before December 29, 2025 - The National Law Review
Smart Money Is Buying Avantor Inc (AVTR) - The Acquirer's Multiple
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Avantor, Inc. (AVTR) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
Avantor, Inc. (AVTR) Stock Analysis: Navigating Potential Upside Amidst Market Challenges - DirectorsTalk Interviews
Did You Lose Money on Avantor, Inc. (AVTR)? Levi & Korsinsky Urges Investors to Act Before December 29, 2025 - The National Law Review
Class Action Filed Against Avantor, Inc. (AVTR) Over Securities ViolationsContact Levi & Korsinsky Today - The National Law Review
Investors in Avantor, Inc. (AVTR): Protect Your RightsContact Levi & Korsinsky Before December 29, 2025 - The National Law Review
Securities Fraud Class Action Filed Against Avantor, Inc. (AVTR) - The National Law Review
J.T.Baker BAKERBOND ABx05 resin from Avantor Inc.single-use columns for tighter mAb polishing - Ad-hoc-news.de
Avantor (NYSE:AVTR) Rebound Puts Valuation Debate Back In Focus - Kalkine Media
Avantor shares drop more than 5% as turnaround efforts fail to excite investors - MSN
Bernstein Maintains Avantor(AVTR.US) With Hold Rating, Cuts Target Price to $10.5 - Moomoo
Bernstein resumes Avantor stock coverage with Market Perform rating - Investing.com
Bernstein resumes Avantor stock coverage with Market Perform rating By Investing.com - Investing.com Canada
Avantor, Inc. Actuals & Estimates (NYSE:AVTR) - TradingView
Avantor Inc (AVTR) Shares Surge 4.0% -- What GF Score of 61 Tells Investors - GuruFocus
Why Avantor (AVTR) Stock Is Up Today - Yahoo Finance
AVTR Forecast — Price Target — Prediction for 2027 - TradingView
Avantor Inc earnings calendar and analyst views, shares on NASDAQ watch - AD HOC NEWS
Price to earnings forward of Avantor, Inc. – NYSE:AVTR - TradingView
Price to sales forward of Avantor, Inc. – NYSE:AVTR - TradingView
Price to earnings forward of Avantor, Inc. – XETR:AVG - TradingView
Enterprise value to EBITDA forward of Avantor, Inc. – XETR:AVG - TradingView
Enterprise value to EBIT forward of Avantor, Inc. – NYSE:AVTR - TradingView
Price to book forward of Avantor, Inc. – XETR:AVG - TradingView
How Avantor Inc. (AVTR) Affects Rotational Strategy Timing - Stock Traders Daily
Barclays Maintains Avantor(AVTR.US) With Sell Rating, Raises Target Price to $8 - Moomoo
Avantor Inc (AVTR) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Avantor, Inc. (AVTR) And Encourages Investors to Reach Out - ACCESS Newswire
2026-06-23 | Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Avantor, Inc. (AVTR) And Encourages Investors to Reach Out | NYSE:AVTR | Press Release - Stockhouse
Form 4 Avantor Inc For: 22 June By Investing.com - Investing.com Nigeria
Avantor (AVTR) executive has shares withheld to cover RSU taxes - Stock Titan
Avantor refocuses on biopharma and lab services, shares in S&P 500 health tech cohort spotlight - AD HOC NEWS
Avantor, Inc. (AVTR) Stock Analysis: A Healthcare Giant with Limited Upside and Mixed Ratings - DirectorsTalk Interviews
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Avantor, Inc. (AVTR) And Encourages Stockholders to Reach Out - ACCESS Newswire
Why Avantor’s J.T.Baker BAKERBOND ABx resin is drawing quiet attention in bioprocessing labs - AD HOC NEWS
What Avantor (AVTR)'s Wolfe Underperform Call Means For Shareholders - simplywall.st
Q1 Rundown: Avantor (NYSE:AVTR) Vs Other Research Tools & Consumables Stocks - Yahoo Finance
Why Avantor J.T.Baker BAKERBOND ABx Pro columns aim for cleaner bioprocessing - AD HOC NEWS
Avantor Inc (AVTR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Avantor Inc (AVTR) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Avantor Inc (AVTR) Valuation: PE, PB & Fair Value Analysis - TradingKey
Avantor Inc (AVTR) Institutional Confidence - TradingKey
Avantor Inc (AVTR) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Avantor Inc (AVTR) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Avantor Inc (AVTR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Avantor Inc (AVTR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Avantor (AVTR) Gets Underperform Rating From Wolfe Research - Yahoo Finance
Avantor Inc Stock (AVTR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Avantor Inc Stock (AVTR) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Dingemans Simon | Director |
May 01 '26 |
Buy |
8.14 |
25,000 |
203,500 |
25,000 |
| MEHRA SANJEEV K | Director |
Mar 10 '26 |
Buy |
8.01 |
125,000 |
1,001,250 |
475,000 |
| LUCIER GREGORY T | Director |
Feb 19 '26 |
Buy |
9.16 |
50,000 |
458,000 |
50,000 |
| SUMME GREGORY L | Director |
Feb 12 '26 |
Buy |
9.40 |
100,000 |
940,000 |
400,000 |
| MEHRA SANJEEV K | Director |
Dec 05 '25 |
Buy |
11.09 |
350,000 |
3,881,500 |
350,000 |
| Ligner Emmanuel | President and CEO |
Nov 17 '25 |
Buy |
11.35 |
87,500 |
993,125 |
283,424 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):